IMVT
NASDAQ HealthcareImmunovant, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $24.99 |
|---|---|
| Volume | 839,621 |
| Market Cap | 5.09B |
| Beta | 0.620 |
| RSI (14-Day) | 33.8 |
| 200-Day MA | $20.52 |
| 50-Day MA | $26.29 |
| 52-Week High | $29.25 |
| 52-Week Low | $12.72 |
| Forward P/E | -9.71 |
| Price / Book | 5.15 |
🎯 Investment Strategy Scores
How IMVT scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
42/100
High dividend yield + low volatility
🚀 Moon Shot
37/100
High growth potential (high beta + oversold)
🔪 Falling Knife
32/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
41/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
60/100
Large-cap, institutional-quality stocks
Find IMVT in your text
Paste any text on the homepage — the tool will extract IMVT and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.